Morepen Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Morepen Laboratories has a total shareholder equity of ₹7.9B and total debt of ₹277.6M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are ₹11.9B and ₹4.1B respectively. Morepen Laboratories's EBIT is ₹1.1B making its interest coverage ratio 58.4. It has cash and short-term investments of ₹578.4M.
Key information
3.5%
Debt to equity ratio
₹277.55m
Debt
Interest coverage ratio | 58.4x |
Cash | ₹578.44m |
Equity | ₹7.89b |
Total liabilities | ₹4.05b |
Total assets | ₹11.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500288's short term assets (₹8.2B) exceed its short term liabilities (₹3.7B).
Long Term Liabilities: 500288's short term assets (₹8.2B) exceed its long term liabilities (₹390.4M).
Debt to Equity History and Analysis
Debt Level: 500288 has more cash than its total debt.
Reducing Debt: 500288's debt to equity ratio has reduced from 67.1% to 3.5% over the past 5 years.
Debt Coverage: 500288's debt is well covered by operating cash flow (225.1%).
Interest Coverage: 500288's interest payments on its debt are well covered by EBIT (58.4x coverage).